1-6 of 6
Jimena Cannata-Ortiz
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Liposomal Doxorubicin in Aggressive B Cell Lymphoma Has Similar Efficacy to the Conventional Formulation: Results from a Retrospective Cohort Study

Evelyn Acuña Cruz, MD, Jimena Cannata Ortiz, MD, Ana García-Noblejas, MD, Adrian Alegre, Reyes Arranz Sáez, MD
Journal: Blood
Blood (2015) 126 (23): 5106.
https://doi.org/10.1182/blood.V126.23.5106.5106
Published: 2015
Journal Articles

Outcome and Long Term Toxicity of the LNH- PRO Trial after 12 Year Median Follow-up, in Patients with Indolent Non Hodgkin's Lymphoma Who Received Immunochemotherapy with CVP and Interferon-alfa2b (IFNα2b)

Jimena Cannata-Ortiz, MD, Concepción Nicolás, MD, Ana García-Noblejas, MD, Javier Lopez, Pilar Sabin, Pilar Zamora, Maria José Requena, Reyes Arranz, MD PhD
Journal: Blood
Blood (2014) 124 (21): 4465.
https://doi.org/10.1182/blood.V124.21.4465.4465
Published: 2014
Journal Articles

Autologous Stem Cell Transplantation in Patients with Mantle Cell Lymphoma: A Retrospective Study of the Geltamo Group (1994-2011)

Ana García-Noblejas, MD, Eulogio Conde, MD PhD, Alejandro Martín, MD, María Jesús Vidal, MD, Rafael Rojas, PhD, Carlos Grande, MD, María José Ramirez, MD, Jimena Cannata-Ortiz, MD, Juan Carlos García-Ruiz, MD, Javier Briones, MD, Andrés Lopez, MD, Pablo Ríos Rull, MD, Victor Noriega, MD, Guillermo Deben, MD, Eva González Barca, MD PhD, Sonia González de Villambrosia, MD, Jose Javier Ferreiro, MD, Juan José Lahuerta, MD PhD, Maria Dolores Caballero, MD PhD, Reyes Arranz, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3980.
https://doi.org/10.1182/blood.V124.21.3980.3980
Published: 2014
Journal Articles

Clinical and Biological Prognostic Factors Evaluation of Diffuse Large B-Cell Lymphoma Patients Relapsed or Refractory After Previous Line with Rituximab Plus Chemotherapy. Results of the Study PRO-R-IPI (NCT01369784),

Carlos Panizo, MD, Anny Jaramillo, MD, Gonzalo Gutierrez-Garcia, Francisco Javier Díaz, Eva González-Barca, MD, Raquel de Oña, Nerea Castro, Juan Manuel Sancho, María Flor García-Alvarez, Blanca Sanchez-Gonzalez, MD, PhD, Francisco Javier Peñalver, Jimena Cannata-Ortiz, Manuel Espeso, María José Requena, Santiago Gardella, Soledad Durán, Ana Pilar González-Rodríguez, Ricardo García-Muñoz, Maurizio Bendandi, MD, PhD, Dolores Caballero, MD
Journal: Blood
Blood (2011) 118 (21): 3654.
https://doi.org/10.1182/blood.V118.21.3654.3654
Published: 2011
Journal Articles

Bendamustine for Mantle Cell Lymphoma: Retrospective Analysis of the Spanish Experience

Ana García-Noblejas, MD, Belén Navarro Matilla, MD, Carolina Da Silva Rodriguez, Raquel De Oña Navarrete, MD, María José Ramirez Sánchez, MD, Concepción Nicolás, MD, Ricardo Pérez Fernández, Blanca Sanchez Gonzalez, MD, Eva Domingo-Domènech, MD, Jose Javier Sanchez Blanco, MD, Jimena Cannata-Ortiz, MD, Tomás José González-López, MD, Reyes Arranz Sáez, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 4942.
https://doi.org/10.1182/blood.V118.21.4942.4942
Published: 2011
Journal Articles

The Addition of Rituximab to CVP (Bagley) + Interferon-α as Induction Regimen, Significantly Increases Complete Remission Rates and Progression Free Survival In Intermediate-High Risk Follicular Lymphoma Patients (LNH-pro vs . LNH-pro-05 trial)

Jimena Cannata-Ortiz, Concepción Nicolás, Ana García-Noblejas, Javier Lopez, Maria José Requena, Concepción Alaez, Adrian Alegre, Reyes Arranz
Journal: Blood
Blood (2010) 116 (21): 2867.
https://doi.org/10.1182/blood.V116.21.2867.2867
Published: 2010